Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, Q2 2026
11,688
Period ended Jun 30, 2026
Change on a year earlier
+57.4%
7,428 in Q2 2025
History
65 quarters
Since Q4 2006
Sources
62
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total stockholders' equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 11,688 | +57.4% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 9,190 | +48.1% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 8,658 | +47.3% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 9,619 | +27.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 7,428 | +25.4% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 6,207 | +23.6% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 5,877 | -5.7% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2024 | Sep 30, 2024 | 7,527 | -1.7% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 5,925 | -12.6% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 5,022 | -6.1% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 6,232 | +70.2% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | 7,656 | +109.6% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | 6,781 | +180.3% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 5,348 | +483.8% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 3,661 | -45.4% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2022 | Sep 30, 2022 | 3,653 | -55.5% | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,419 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 916 | -90.2% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | 6,700 | -28.8% | Form 10-K (filed 2022-02-16) ↗ |
| Q3 2021 | Sep 30, 2021 | 8,217 | -25.0% | Form 10-Q (filed 2021-11-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 9,334 | -1.6% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | 9,409 | -2.7% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 10,959 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | 10,659 | -1.3% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 9,485 | -12.4% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 9,673 | -22.6% | Form 10-K (filed 2020-02-12) ↗ |
| Q2 2019 | Jun 30, 2019 | 10,794 | -27.6% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 10,832 | -30.7% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 12,500 | -50.5% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 14,349 | -55.5% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 14,909 | -53.0% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | 15,620 | -49.0% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | 25,241 | -15.5% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 32,229 | +4.7% | Form 10-Q (filed 2017-10-26) ↗ |
| Q2 2017 | Jun 30, 2017 | 31,722 | +5.3% | Form 10-Q (filed 2017-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | 30,637 | +6.8% | Form 10-Q (filed 2017-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | 29,875 | +6.4% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2016 | Sep 30, 2016 | 30,773 | +10.0% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 30,133 | +9.6% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2016 | Mar 31, 2016 | 28,682 | +8.2% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2015 | Dec 31, 2015 | 28,083 | +8.9% | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2015 | Sep 30, 2015 | 27,967 | +10.4% | Form 10-Q (filed 2015-11-02) ↗ |
| Q2 2015 | Jun 30, 2015 | 27,484 | +12.7% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 26,506 | +16.6% | Form 10-Q (filed 2015-04-27) ↗ |
| Q4 2014 | Dec 31, 2014 | 25,778 | +16.7% | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | 25,325 | +16.6% | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 24,382 | – | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 22,741 | +16.7% | Form 10-Q (filed 2014-04-30) ↗ |
| Q4 2013 | Dec 31, 2013 | 22,096 | +15.9% | Form 10-K (filed 2014-02-24) ↗ |
| Q3 2013 | Sep 30, 2013 | 21,728 | +9.2% | Form 10-Q (filed 2013-10-29) ↗ |
| Q1 2013 | Mar 31, 2013 | 19,491 | – | Form 10-Q (filed 2013-05-03) ↗ |
| Q4 2012 | Dec 31, 2012 | 19,060 | +0.2% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 19,902 | – | Form 10-Q (filed 2012-11-06) ↗ |
| Q4 2011 | Dec 31, 2011 | 19,029 | -20.5% | Form 10-K (filed 2012-02-29) ↗ |
| Q1 2011 | Mar 31, 2011 | 24,984 | +11.8% | Form 10-Q (filed 2011-05-10) ↗ |
| Q4 2010 | Dec 31, 2010 | 23,944 | +5.6% | Form 10-K (filed 2011-02-25) ↗ |
| Q3 2010 | Sep 30, 2010 | 24,071 | +5.3% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 23,170 | +8.5% | Form 10-Q (filed 2010-08-09) ↗ |
| Q1 2010 | Mar 31, 2010 | 22,339 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 22,667 | +8.5% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 22,858 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 21,360 | – | Form 10-Q (filed 2009-08-10) ↗ |
| Q4 2008 | Dec 31, 2008 | 20,885 | +12.8% | Form 10-Q (filed 2009-08-10) ↗ |
| Q4 2007 | Dec 31, 2007 | 18,512 | -6.7% | Form 10-K (filed 2010-03-01) ↗ |
| Q4 2006 | Dec 31, 2006 | 19,841 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Amgen Total stockholders' equity ($M) ($M), quarterly Q4 2006–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_eq
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.